ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 179 filers reported holding ARCUS BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 2.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $80,664,033 | -10.4% | 4,493,818 | +1.4% | 0.00% | 0.0% |
| Q2 2023 | $90,029,721 | +11.6% | 4,432,778 | +0.2% | 0.00% | 0.0% |
| Q1 2023 | $80,687,540 | -10.8% | 4,423,659 | +1.2% | 0.00% | 0.0% |
| Q4 2022 | $90,437,300 | -22.4% | 4,373,177 | -1.9% | 0.00% | -33.3% |
| Q3 2022 | $116,600,000 | +7.4% | 4,457,184 | +4.1% | 0.00% | 0.0% |
| Q2 2022 | $108,540,000 | -2.1% | 4,283,330 | +22.0% | 0.00% | 0.0% |
| Q1 2022 | $110,843,000 | -20.1% | 3,512,114 | +2.5% | 0.00% | 0.0% |
| Q4 2021 | $138,664,000 | +61.2% | 3,426,336 | +38.9% | 0.00% | +50.0% |
| Q3 2021 | $86,007,000 | +27.0% | 2,466,479 | +0.0% | 0.00% | 0.0% |
| Q2 2021 | $67,730,000 | -4.5% | 2,466,442 | -2.3% | 0.00% | 0.0% |
| Q1 2021 | $70,897,000 | +16.3% | 2,524,849 | +7.5% | 0.00% | 0.0% |
| Q4 2020 | $60,944,000 | +61.2% | 2,347,624 | +6.4% | 0.00% | +100.0% |
| Q3 2020 | $37,811,000 | -30.3% | 2,205,940 | +0.6% | 0.00% | -50.0% |
| Q2 2020 | $54,257,000 | +156.3% | 2,193,120 | +43.8% | 0.00% | +100.0% |
| Q1 2020 | $21,167,000 | +50.0% | 1,525,094 | +9.1% | 0.00% | – |
| Q4 2019 | $14,112,000 | +11.1% | 1,397,250 | +0.1% | 0.00% | – |
| Q3 2019 | $12,697,000 | +46.2% | 1,395,262 | +27.7% | 0.00% | – |
| Q2 2019 | $8,685,000 | -40.2% | 1,092,421 | -6.0% | 0.00% | -100.0% |
| Q1 2019 | $14,512,000 | +20.9% | 1,161,946 | +4.3% | 0.00% | 0.0% |
| Q4 2018 | $12,000,000 | +90.3% | 1,114,202 | +146.3% | 0.00% | – |
| Q3 2018 | $6,307,000 | +17.1% | 452,409 | +2.8% | 0.00% | – |
| Q2 2018 | $5,385,000 | +480.9% | 439,898 | +633.2% | 0.00% | – |
| Q1 2018 | $927,000 | – | 60,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |